I-VAC
Toolkit

Last Updated November 22, 2022

COVID-19 VACCINE ADMINISTRATION
SELF-GUIDED EDUCATION MODULES

This toolkit is specifically designed to aide clinicians and healthcare organizations in developing effective tactics for the incorporation of COVID-19 vaccination into routine clinical workflows. This toolkit is not meant to replace required federal or state trainings, but to act as supplemental information to help drive more efficient vaccine implementation throughout Illinois.

The information provided within these toolkits and on this landing page was last updated on November 22, 2022.

This Toolkit Includes Information and Resources On:

  • COVID-19 vaccine administration and distribution (I-CARE, working with local health departments, etc.)
  • Operational issues
  • Handling and preparation of COVID-19 vaccines
  • Post-vaccine process
  • Implementing COVID-19 vaccine mandates in your workplace
  • Strategies for overcoming vaccine hesitancy through culturally and linguistically appropriate methods
  • How to use data to support vaccine uptake

HOW TO USE THIS TOOLKIT

Download the complete toolkit or individual sections based on your needs. Each toolkit section includes an interactive PDF with live links to key resources and source material.

All resources and source material links for each toolkit section can be found under the “Resources” portion of this page, organized by section and page number.

Woman Being Vaccinated

Download Toolkit

Last Updated November 22, 2022

Download
Purpose of This Toolkit
Download
About
Download
Becoming a Vaccinator
Download
Vaccine Ordering, Storage, and Handling
Download
Vaccine Administration
Download
Clinical Considerations
Download
Download
Additional Considerations
Download

RESOURCE LINKS

If you are using the printed version of the self-guided COVID-19 vaccination toolkit, please use the resource guide below to view all corresponding resources and source material by section. Here you will find all the links to each resource referenced within the toolkit.

5-6

Appendix E

Considerations for Janssen COVID-19 Vaccine

5-7

Appendix E

See COVID-19‭ ‬vaccination and MIS-C and MIS-A

COVID-19 vaccination and myocarditis and pericarditis

Considerations for Janssen COVID-19 Vaccine

5-8

Appendix E

Clinical Immunization Safety Assessment COVIDvax

Appendix E

Frequently Asked Questions

Managing Anaphylaxis

5-9

CDC: Use of COVID-19 Vaccines in the United States

CDC: Contraindications and Precautions

Illinois.gov: Vaccination Eligibility

5-10

CDC’s latest recommendations

5-11

Pfizer-BioNTech COVID-19 Vaccine Guidance

CDC

CDC’s Guidance

5-12

CDC

CDC’s Guidance

5-13

Moderna COVID-19 Vaccine Guidance

CDC

CDC’s Guidance

5-14

CDC

CDC’s Guidance

5-15

CDC’s Guidance

5-16

Timing‭, ‬spacing‭, ‬and interchangeability of COVID-19‭ ‬vaccines

5-17

CDC: Use of COVID-19 Vaccines in the United States

CDC: COVID-19 Vaccine Boosters

CDC: Updates to the Evidence to Recommendation Framework: Pfizer-BioNTech and Moderna COVID-19 vaccine booster doses

5-18

Timing‭, ‬spacing‭, ‬and interchangeability of COVID-19‭ ‬vaccines

COVID-19 Vaccine: Vaccine Administration Competencies Assessment Form-February 28, 2021

5-19

For supplementary material on Intramuscular Injection Children 7 through 18 years of age please follow this PDF.

CDC: Vaccine Administration: Needle Gauge and Length

5-20

CDC: Use of COVID-19 Vaccines in the United States

5-21

Encourage patients to enroll in V-SAFE

CDC: How to Increase COVID-19 Vaccination upon Discharge from Hospitals, Emergency Departments & Urgent Care Facilities

5-22

From the CDC: There is no VIS for COVID-19 vaccines authorized under an EUA. Instead, the FDA-issued EUA Fact Sheet for Recipients and Caregivers for each COVID-19 vaccine must be used.

CDC: Healthcare Providers/ Professionals

5-23

CDC: Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

5-25

Here: IDPH Account Portal

IDPH: Vax Verify

5-27

CDC: v-safe After Vaccination Health Checker

5-30

Suburban Cook County In-Home COVID-19 Vaccination Contact Form

5-31

Far South Region – Protect Chicago at Home Program

Near South Region – Protect Chicago at Home Program

North/Central Region – Protect Chicago at Home Program

Northwest Region – Protect Chicago at Home Program

Southwest Region – Protect Chicago at Home Program

West Region – Protect Chicago at Home Program

5-32

DuPage County COVID-19 Vaccine Registration

5-33

Will County In-Home COVID-19 Vaccination Contact Form

5-35

U.S. COVID-19 Vaccine Product Information

Moderna

Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 12 Years Through 17 Years of Age

Moderna COVID-19 Vaccine: Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older

Pfizer

6 Months Through 4 Years of Age Pfizer BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine

Pfizer-BioNTech COVID-19 Vaccine: 5 Through 11 Years of Age • Standing Orders for Administering Vaccine

12 Years of Age and Older (Gray Cap) Pfizer-BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine

Novavax

Novavax COVID-19 Vaccine (Monovalent) Standing Orders for Administering Vaccine to Persons 12 Years of Age and Older

Janssen

Janssen COVID-19 Vaccine (Johnson & Johnson) Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older

6-3

Pfizer Local & Systematic Reactions

Moderna Local & Systematic Reactions

Novavax Local & Systematic Reactions

J&J Local & Systematic Reactions

6-4

NIH: Q&A: COVID-19, Vaccines, and Myocarditis

6-5

CDC: Update on myocarditis following mRNA COVID-19 vaccination

CDC: Recommendations for Pfizer-BioNTech and Moderna COVID-19 Vaccine Primary Series in Children 6 Months through 5 Years Old

6-7

CDC: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

6-8

CDC Center for Preparedness and Response

CDC: Pfizer/BioNTech BNT162b2 (COVID-19 Vaccine, mRNA) Vaccine –in Individuals 5 to <12 Years of Age

6-9

VAERS: Writable PDF Form

VAERS: Upload Completed Writable PDF Form

CDC: Reporting Adverse Events Following Vaccination

6-10

CDC: COVID-19 Vaccine Administration Errors and Deviations

6-13

CDC: Table 2

CDC: Table 3

6-15

CDC: COVID-19 Vaccine Administration Errors and Deviations

6-16

CDC: Science Brief

CDC: Morbidity and Mortality Weekly Report, January 14, 2022

6-19

COVID-19 Vaccines for Moderately or Severely Immunocompromised People

6-21

CDC: Use of COVID-19 Vaccines in the United States

6-22

CDC: Use of COVID-19 Vaccines in the United States

WHO-EUL COVID-19 Vaccines

 6-23

WHO-EUL COVID-19 Vaccines

CDC: Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers: Pfizer-BioNTech COVID-19 Vaccine for Primary, Additional, and/or Booster Doses

6-24

Stillbirths

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

6-26

January 2022 Study

2022 MMWR Study

2021 MMWR Study

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

ACOG Guidelines

6-27

Illinois.gov Guidance Affirming Non-Discrimination in Medical Treatment

CDC: People with Disabilities

CDC’s Website